|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D12.7 |
Benign neoplasm of rectosigmoid junction
|
D127 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 13.25%
|
33.86%
|
21.91%
|
13.89%
|
7.78%
|
4.03%
|
2.12%
|
1.20%
|
0.66%
|
0.46%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D12.7*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
2,565
|
5,250
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,411
|
52,821
|
|
45385
|
COLONOSCOPY W/LESION REMOVAL |
1,268
|
1,268
|
|
45380
|
COLONOSCOPY AND BIOPSY |
912
|
912
|
|
J7120
|
RINGERS LACTATE INFUSION |
501
|
568
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
431
|
1,820
|
|
J3010
|
FENTANYL CITRATE INJECTION |
397
|
671
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
335
|
335
|
|
J2001
|
LIDOCAINE INJECTION |
294
|
3,209
|
|
J7030
|
NORMAL SALINE SOLUTION INFUS |
211
|
225
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
184
|
393
|
|
82962
|
GLUCOSE BLOOD TEST |
166
|
195
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
150
|
169
|
|
G0500
|
MOD SEDAT ENDO SERVICE >5YRS |
148
|
148
|
|
45381
|
COLONOSCOPY SUBMUCOUS NJX |
146
|
146
|
|
99153
|
MOD SED SAME PHYS/QHP EA |
125
|
198
|
|
J2405
|
ONDANSETRON HCL INJECTION |
124
|
501
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
112
|
112
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
111
|
221
|
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
94
|
94
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D12.7 related to the following DRG Codes:
393-395
|
